{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T02:35:27Z","timestamp":1792377327196,"version":"4.4.0"},"reference-count":234,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.semcancer.2019.05.001","type":"journal-article","created":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T10:25:52Z","timestamp":1558175152000},"page":"51-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":234,"special_numbering":"C","title":["Risk of colorectal cancer in inflammatory bowel diseases"],"prefix":"10.1016","volume":"64","author":[{"given":"Muhammad Shahid","family":"Nadeem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad A.","family":"Al-Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amjad","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firoz","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9573","key":"10.1016\/j.semcancer.2019.05.001_bib0005","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","article-title":"Inflammatory bowel disease: cause and immunobiology","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2019.05.001_bib0010","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.semcancer.2019.05.001_bib0015","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/ajg.2013.249","article-title":"Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study","volume":"108","author":"Jess","year":"2013","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.semcancer.2019.05.001_bib0020","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1053\/j.gastro.2005.12.035","article-title":"Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis","volume":"130","author":"Rutter","year":"2006","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.semcancer.2019.05.001_bib0025","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/ibd\/izx104","article-title":"Malignancy and mortality in pediatric-onset inflammatory bowel disease: a systematic review","volume":"24","author":"Aardoom","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"issue":"6","key":"10.1016\/j.semcancer.2019.05.001_bib0030","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.semcancer.2019.05.001_bib0035","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41424-018-0013-8","article-title":"Risk of thrombosis and mortality in inflammatory bowel disease","volume":"9","author":"Andrade","year":"2018","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"6","key":"10.1016\/j.semcancer.2019.05.001_bib0040","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1053\/j.gastro.2011.01.057","article-title":"Intestinal inflammation and cancer","volume":"140","author":"Ullman","year":"2011","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"10.1016\/j.semcancer.2019.05.001_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2036.18.s2.2.x","article-title":"Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease","volume":"18","author":"Munkholm","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.semcancer.2019.05.001_bib0050","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0055","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ibd.21048","article-title":"World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010.%A Bernstein CN","volume":"16","author":"Bernstein","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"issue":"9573","key":"10.1016\/j.semcancer.2019.05.001_bib0060","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.semcancer.2019.05.001_bib0065","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.7150\/thno.18183","article-title":"Dexamethasone-loaded polymeric nanoconstructs for monitoring and treating inflammatory bowel disease","volume":"7","author":"Lee","year":"2017","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.gastro.2008.10.018","article-title":"RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F","volume":"136","author":"Leppkes","year":"2009","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.semcancer.2019.05.001_bib0075","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jaad.2018.06.024","article-title":"Inflammatory bowel disease events after exposure to interleukin 17 inhibitors secukinumab and ixekizumab: postmarketing analysis from the RADAR (\"Research on Adverse Drug events and Reports\") program","volume":"79","author":"Orrell","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9","key":"10.1016\/j.semcancer.2019.05.001_bib0080","article-title":"Metformin ameliorates inflammatory bowel disease by suppression of the STAT3 signaling pathway and regulation of the between Th17\/Treg balance","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.semcancer.2019.05.001_bib0085","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMe0811014","article-title":"Interleukin-1beta and the autoinflammatory diseases","volume":"360","author":"Dinarello","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.semcancer.2019.05.001_bib0090","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.4049\/jimmunol.162.11.6829","article-title":"IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn\u2019s disease: expression and localization in intestinal mucosal cells","volume":"162","author":"Pizarro","year":"1999","journal-title":"J Immunol"},{"issue":"28","key":"10.1016\/j.semcancer.2019.05.001_bib0095","doi-asserted-by":"crossref","first-page":"8711","DOI":"10.3748\/wjg.v21.i28.8711","article-title":"Interleukin-18 genetic polymorphisms contribute differentially to the susceptibility to Crohn\u2019s disease","volume":"21","author":"Gao","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.semcancer.2019.05.001_bib0100","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/gast.2001.28021","article-title":"Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn\u2019s disease","volume":"121","author":"Kanai","year":"2001","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0105","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-2249.2004.02362.x","article-title":"Involvement of interleukin 18 in Crohn\u2019s disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models","volume":"135","author":"Maerten","year":"2004","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.semcancer.2019.05.001_bib0110","first-page":"753","article-title":"Interleukin-10 receptor gene mutations induced very early onset inflammatory bowel disease in 6 infants","volume":"56","author":"Wang","year":"2018","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"5","key":"10.1016\/j.semcancer.2019.05.001_bib0115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.semcancer.2019.05.001_bib0120","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/ibd.21175","article-title":"Characterization of the novel ST2\/IL-33 system in patients with inflammatory bowel disease","volume":"16","author":"Beltran","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"issue":"10","key":"10.1016\/j.semcancer.2019.05.001_bib0125","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00535-010-0245-1","article-title":"Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis","volume":"45","author":"Kobori","year":"2010","journal-title":"J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.semcancer.2019.05.001_bib0130","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3892\/ijo.2014.2259","article-title":"The IL-6\/JAK\/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review)","volume":"44","author":"Wang","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.semcancer.2019.05.001_bib0135","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/MIB.0000000000000729","article-title":"PDCD4 deficiency aggravated colitis and colitis-associated colorectal Cancer via promoting IL-6\/STAT3 pathway in mice","volume":"22","author":"Wang","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"issue":"8","key":"10.1016\/j.semcancer.2019.05.001_bib0140","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1111\/j.1572-0241.1999.01288.x","article-title":"Clinical relevance of serum interleukin-6 in Crohn\u2019s disease: single point measurements, therapy monitoring, and prediction of clinical relapse","volume":"94","author":"Reinisch","year":"1999","journal-title":"Am. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/gut.2009.184176","article-title":"Disease-related expression of the IL6\/STAT3\/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis","volume":"59","author":"Li","year":"2010","journal-title":"Gut"},{"issue":"27","key":"10.1016\/j.semcancer.2019.05.001_bib0150","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.3748\/wjg.14.4280","article-title":"Role of cytokines in inflammatory bowel disease","volume":"14","author":"Sanchez-Munoz","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0155","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03670-6","article-title":"WASP-mediated regulation of anti-inflammatory macrophages is IL-10 dependent and is critical for intestinal homeostasis","volume":"9","author":"Biswas","year":"2018","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.semcancer.2019.05.001_bib0160","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3748\/wjg.v10.i5.620","article-title":"IL-10 and its related cytokines for treatment of inflammatory bowel disease","volume":"10","author":"Li","year":"2004","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0165","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41385-018-0085-5","article-title":"Non-toxigenic Bacteroides fragilis (NTBF) administration reduces bacteria-driven chronic colitis and tumor development independent of polysaccharide A","volume":"12","author":"Chan","year":"2019","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2249.2003.02268.x","article-title":"Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis","volume":"134","author":"Melgar","year":"2003","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0175","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/cbf.3250","article-title":"Tumor necrosis factor suppresses interleukin 10 in peripheral B cells via upregulating Bcl2-like protein 12 in patients with inflammatory bowel disease","volume":"35","author":"Guo","year":"2017","journal-title":"Cell Biochem. Funct."},{"issue":"5","key":"10.1016\/j.semcancer.2019.05.001_bib0180","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.humimm.2011.02.014","article-title":"The effect of IL-10 genetic variation and interleukin 10 serum levels on Crohn\u2019s disease susceptibility in a New Zealand population","volume":"72","author":"Wang","year":"2011","journal-title":"Hum. Immunol."},{"issue":"3","key":"10.1016\/j.semcancer.2019.05.001_bib0185","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2008.07.025","article-title":"TGF-beta: a master of all T cell trades","volume":"134","author":"Li","year":"2008","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0190","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1365-2249.2003.02250.x","article-title":"TGF-beta1 production in inflammatory bowel disease: differing production patterns in Crohn\u2019s disease and ulcerative colitis","volume":"134","author":"Del Zotto","year":"2003","journal-title":"Clin. Exp. Immunol."},{"issue":"7","key":"10.1016\/j.semcancer.2019.05.001_bib0195","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/eji.201041135","article-title":"TGF-beta limits IL-33 production and promotes the resolution of colitis through regulation of macrophage function","volume":"41","author":"Rani","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0200","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1476-4598-10-150","article-title":"IL-17 induces AKT-dependent IL-6\/JAK2\/STAT3 activation and tumor progression in hepatocellular carcinoma","volume":"10","author":"Gu","year":"2011","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.semcancer.2019.05.001_bib0205","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/ard.2010.132720","article-title":"Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice","volume":"70","author":"Wruck","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/09546634.2017.1329511","article-title":"Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease","volume":"29","author":"Hohenberger","year":"2018","journal-title":"J. Dermatol. Treat."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0215","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.semcancer.2019.05.001_bib0220","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1053\/j.gastro.2009.07.049","article-title":"Th1\/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn\u2019s disease","volume":"137","author":"Sakuraba","year":"2009","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.semcancer.2019.05.001_bib0225","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1084\/jem.20081712","article-title":"Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation","volume":"206","author":"Kleinschek","year":"2009","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.semcancer.2019.05.001_bib0230","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/MOG.0b013e328339d099","article-title":"Proinflammatory cytokines underlying the inflammation of Crohn\u2019s disease","volume":"26","author":"Strober","year":"2010","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0235","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.imlet.2016.05.001","article-title":"IL-17+ CD8+ T cells: differentiation, phenotype and role in inflammatory disease","volume":"178","author":"Srenathan","year":"2016","journal-title":"Immunol. Lett."},{"issue":"1-2","key":"10.1016\/j.semcancer.2019.05.001_bib0240","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.vetimm.2013.09.017","article-title":"Markedly increased expression of interleukin-8 in the colorectal mucosa of inflammatory colorectal polyps in miniature dachshunds","volume":"156","author":"Tamura","year":"2013","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"3","key":"10.1016\/j.semcancer.2019.05.001_bib0245","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/cs0820273","article-title":"Enhanced synthesis of neutrophil-activating peptide-1\/interleukin-8 in active ulcerative colitis","volume":"82","author":"Mahida","year":"1992","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0250","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1023\/B:JOCI.0000018066.46279.6b","article-title":"Increased expression of CCL20 in human inflammatory bowel disease","volume":"24","author":"Kaser","year":"2004","journal-title":"J. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.semcancer.2019.05.001_bib0255","first-page":"603","article-title":"CCL20 is negatively regulated by TGF-beta1 in intestinal epithelial cells and reduced in Crohn\u2019s Disease patients with a successful response to mongersen, a Smad7 antisense oligonucleotide","volume":"11","author":"Marafini","year":"2017","journal-title":"J. Crohns Colitis"},{"issue":"8","key":"10.1016\/j.semcancer.2019.05.001_bib0260","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1074\/jbc.C200673200","article-title":"Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn\u2019s disease","volume":"278","author":"Inohara","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.semcancer.2019.05.001_bib0265","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/jgh.12955","article-title":"Defective macrophage handling of Escherichia coli in Crohn\u2019s disease","volume":"30","author":"Elliott","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0270","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nm.2069","article-title":"NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation","volume":"16","author":"Cooney","year":"2010","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0275","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ni.1823","article-title":"Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry","volume":"11","author":"Travassos","year":"2010","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0280","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.it.2010.12.007","article-title":"The ever-expanding function of NOD2: autophagy, viral recognition, and T cell activation","volume":"32","author":"Shaw","year":"2011","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.semcancer.2019.05.001_bib0285","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/cei.12471","article-title":"Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn\u2019s associated NOD2 gene variants","volume":"179","author":"Salem","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.semcancer.2019.05.001_bib0290","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/ni.1782","article-title":"Activation of innate immune antiviral responses by Nod2","volume":"10","author":"Sabbah","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0295","article-title":"The role of the NOD2\/CARD15 gene in surgical treatment prediction in patients with Crohn\u2019s disease","author":"Kunovsky","year":"2018","journal-title":"Int. J. Colorectal. Dis."},{"issue":"12","key":"10.1016\/j.semcancer.2019.05.001_bib0300","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ng.717","article-title":"Genome-wide meta-analysis increases to 71 the number of confirmed Crohn\u2019s disease susceptibility loci","volume":"42","author":"Franke","year":"2010","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.semcancer.2019.05.001_bib0305","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/ng2032","article-title":"Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis","volume":"39","author":"Rioux","year":"2007","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.semcancer.2019.05.001_bib0310","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/ng.215","article-title":"Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn\u2019s disease","volume":"40","author":"McCarroll","year":"2008","journal-title":"Nat. Genet."},{"issue":"7351","key":"10.1016\/j.semcancer.2019.05.001_bib0315","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"474","author":"Khor","year":"2011","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.semcancer.2019.05.001_bib0320","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.3748\/wjg.v23.i11.1944","article-title":"Role of autophagy in the pathogenesis of inflammatory bowel disease","volume":"23","author":"Iida","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.semcancer.2019.05.001_bib0325","doi-asserted-by":"crossref","first-page":"e3391","DOI":"10.1371\/journal.pone.0003391","article-title":"Impaired autophagy of an intracellular pathogen induced by a Crohn\u2019s disease associated ATG16L1 variant","volume":"3","author":"Kuballa","year":"2008","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.semcancer.2019.05.001_bib0330","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1172\/JCI120453","article-title":"Interaction between smoking and ATG16L1T300A triggers Paneth cell defects in Crohn\u2019s disease","volume":"128","author":"Liu","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0335","doi-asserted-by":"crossref","first-page":"G95","DOI":"10.1152\/ajpgi.00196.2018","article-title":"Crohn\u2019s disease IRGM risk alleles are associated with altered gene expression in human tissues","volume":"316","author":"Ajayi","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"6","key":"10.1016\/j.semcancer.2019.05.001_bib0340","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0345","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrgastro.2017.136","article-title":"Environmental triggers in IBD: a review of progress and evidence","volume":"15","author":"Ananthakrishnan","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.semcancer.2019.05.001_bib0350","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/s41395-018-0239-9","article-title":"The effect of early-life environmental exposures on disease phenotype and clinical course of Crohn\u2019s disease in children","volume":"113","author":"Lindoso","year":"2018","journal-title":"Am. J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.semcancer.2019.05.001_bib0355","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1007\/s10620-018-5142-0","article-title":"Smoking and inflammatory bowel disease: a comparison of China, India, and the USA","volume":"63","author":"Wang","year":"2018","journal-title":"Dig. Dis. Sci."},{"issue":"46","key":"10.1016\/j.semcancer.2019.05.001_bib0360","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.3748\/wjg.v13.i46.6134","article-title":"Smoking in inflammatory bowel diseases: good, bad or ugly?","volume":"13","author":"Lakatos","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0365","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.intimp.2018.12.015","article-title":"1,25Dihydroxyvitamin D regulates macrophage polarization and ameliorates experimental inflammatory bowel disease by suppressing miR-125b","volume":"67","author":"Zhu","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0370","article-title":"The effect of vitamin D administration on inflammatory markers in patients with inflammatory bowel disease","author":"Jun","year":"2018","journal-title":"Intest. Res."},{"issue":"46","key":"10.1016\/j.semcancer.2019.05.001_bib0375","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012662","article-title":"Efficacy of vitamin D in treatment of inflammatory bowel disease: a meta-analysis","volume":"97","author":"Li","year":"2018","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0380","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/01635581.2017.1263346","article-title":"Vitamin d reduces colitis- and inflammation-associated colorectal Cancer in mice independent of NOD2","volume":"69","author":"Elimrani","year":"2017","journal-title":"Nutr. Cancer"},{"issue":"5","key":"10.1016\/j.semcancer.2019.05.001_bib0385","doi-asserted-by":"crossref","first-page":"G341","DOI":"10.1152\/ajpgi.00105.2015","article-title":"Vitamin D receptor pathway is required for probiotic protection in colitis, American journal of physiology","volume":"309","author":"Wu","year":"2015","journal-title":"Gastrointest. Liver Physiol"},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0390","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000491878","article-title":"Drug lag for inflammatory bowel disease treatments in the east and West","volume":"3","author":"Okabayashi","year":"2018","journal-title":"Inflamm. Intest. Dis."},{"issue":"3","key":"10.1016\/j.semcancer.2019.05.001_bib0395","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcmgh.2018.05.008","article-title":"Increased pancreatic protease activity in response to antibiotics impairs gut barrier and triggers colitis","volume":"6","author":"Yoon","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"464","key":"10.1016\/j.semcancer.2019.05.001_bib0400","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao4755","article-title":"Antibiotics induce sustained dysregulation of intestinal T cell immunity by perturbing macrophage homeostasis","volume":"10","author":"Scott","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.semcancer.2019.05.001_bib0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187737","article-title":"The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: a report from the IBD registry","volume":"12","author":"Fukuda","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2019.05.001_bib0410","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.biopha.2017.02.042","article-title":"Ameliorative effect of chromium-d-phenylalanine complex on indomethacin-induced inflammatory bowel disease in rats","volume":"89","author":"Nagarjun","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.semcancer.2019.05.001_bib0415","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/0003-4819-156-5-201203060-00007","article-title":"Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study","volume":"156","author":"Ananthakrishnan","year":"2012","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0420","article-title":"Fatigue in IBD: epidemiology, pathophysiology and management","volume":"10","author":"Borren","year":"2018","journal-title":"Nat Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.semcancer.2019.05.001_bib0425","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1038\/ajg.2010.398","article-title":"Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease","volume":"105","author":"Shaw","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0430","article-title":"Novel perceived stress and life events precede flares of inflammatory bowel disease: a prospective 12-month follow-up study","author":"Wintjens","year":"2018","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.semcancer.2019.05.001_bib0435","article-title":"Acceptance and commitment therapy reduces psychological stress in patients with inflammatory bowel diseases","author":"Wynne","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.semcancer.2019.05.001_bib0440","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1053\/j.gastro.2018.05.033","article-title":"GABAA receptor subtypes regulate stress-induced Colon inflammation in mice","volume":"155","author":"Seifi","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2019.05.001_bib0445","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejphar.2014.11.016","article-title":"Evaluation of anti-colitic effect of fluvoxamine against acetic acid-induced colitis in normal and reserpinized depressed rats","volume":"746","author":"Minaiyan","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4110\/in.2017.17.1.1","article-title":"Host-microbial cross-talk in inflammatory bowel disease","volume":"17","author":"Nagao-Kitamoto","year":"2017","journal-title":"Immune Netw."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0455","doi-asserted-by":"crossref","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease","author":"Franzosa","year":"2018","journal-title":"Nat. Microbiol."},{"issue":"4","key":"10.1016\/j.semcancer.2019.05.001_bib0460","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jcmgh.2016.02.003","article-title":"Functional characterization of inflammatory bowel disease-associated gut dysbiosis in Gnotobiotic mice","volume":"2","author":"Nagao-Kitamoto","year":"2016","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.semcancer.2019.05.001_bib0465","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/gut.2010.223263","article-title":"Dysbiosis of the faecal microbiota in patients with Crohn\u2019s disease and their unaffected relatives","volume":"60","author":"Joossens","year":"2011","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0470","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10034-5","article-title":"Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients","volume":"7","author":"Santoru","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0475","first-page":"2151","article-title":"Human catestatin alters gut microbiota composition in mice","volume":"7","author":"Rabbi","year":"2016","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170034","article-title":"Intestinal Bacteria composition and translocation of Bacteria in inflammatory bowel disease","volume":"12","author":"Vrakas","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.semcancer.2019.05.001_bib0485","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00535-010-0368-4","article-title":"Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn\u2019s disease using terminal restriction fragment length polymorphism analysis","volume":"46","author":"Andoh","year":"2011","journal-title":"J. Gastroenterol."},{"issue":"39","key":"10.1016\/j.semcancer.2019.05.001_bib0490","doi-asserted-by":"crossref","first-page":"15064","DOI":"10.1073\/pnas.0803124105","article-title":"The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria","volume":"105","author":"Johansson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.semcancer.2019.05.001_bib0495","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1742-1241.2007.01665.x","article-title":"Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn\u2019s disease","volume":"62","author":"Strugala","year":"2008","journal-title":"Int. J. Clin. Pract."},{"issue":"10","key":"10.1016\/j.semcancer.2019.05.001_bib0500","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/ibd.20176","article-title":"Adherent-invasive Escherichia coli in inflammatory bowel disease","volume":"13","author":"Rolhion","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"issue":"8","key":"10.1016\/j.semcancer.2019.05.001_bib0505","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/gutjnl-2015-311059","article-title":"Comparative genomics of Crohn\u2019s disease-associated adherent-invasive Escherichia coli","volume":"66","author":"O\u2019Brien","year":"2017","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193202","article-title":"Increased fecal calprotectin levels in Crohn\u2019s disease correlate with elevated serum Th1- and Th17-associated cytokines","volume":"13","author":"Bourgonje","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2019.05.001_bib0515","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.abb.2018.09.003","article-title":"Bcl2L12 mediates effects of protease-activated receptor-2 on the pathogenesis of Th2-dominated responses of patients with ulcerative colitis","volume":"657","author":"Feng","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"issue":"7673","key":"10.1016\/j.semcancer.2019.05.001_bib0520","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature23910","article-title":"Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring","volume":"549","author":"Kim","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2019.05.001_bib0525","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaut.2018.07.022","article-title":"HIF-1alpha-induced xenobiotic transporters promote Th17 responses in Crohn\u2019s disease","volume":"94","author":"Xie","year":"2018","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0530","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1586\/egh.11.107","article-title":"The IL-23\/IL-17 pathway in inflammatory bowel disease","volume":"6","author":"Geremia","year":"2012","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.semcancer.2019.05.001_bib0535","doi-asserted-by":"crossref","first-page":"431","DOI":"10.15403\/jgld.2014.1121.254.nis","article-title":"Impaired gastric Cancer survival in patients with inflammatory bowel disease","volume":"25","author":"Nissen","year":"2016","journal-title":"J. Gastrointestin. Liver Dis."},{"issue":"15","key":"10.1016\/j.semcancer.2019.05.001_bib0540","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJMra1403718","article-title":"Cancers complicating inflammatory bowel disease","volume":"372","author":"Beaugerie","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0545","article-title":"Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population?","author":"Stjarngrim","year":"2018","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0550","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.canlet.2013.07.032","article-title":"Chronic ulcerative colitis and colorectal cancer","volume":"345","author":"Rogler","year":"2014","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.semcancer.2019.05.001_bib0555","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1038\/s41395-018-0354-7","article-title":"Strategies for detecting colorectal Cancer in patients with inflammatory bowel disease: a cochrane systematic review and meta-analysis","volume":"113","author":"Bye","year":"2018","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0560","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7326\/0003-4819-159-1-201307020-00004","article-title":"Prevalence of advanced colorectal neoplasia in white and black patients undergoing screening colonoscopy in a safety-net hospital","volume":"159","author":"Schroy","year":"2013","journal-title":"Ann. Intern. Med."},{"issue":"6127","key":"10.1016\/j.semcancer.2019.05.001_bib0565","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2019.05.001_bib0570","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2018.12.016","article-title":"Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis","volume":"445","author":"Gao","year":"2018","journal-title":"Cancer Lett."},{"issue":"20","key":"10.1016\/j.semcancer.2019.05.001_bib0575","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.3748\/wjg.v22.i20.4794","article-title":"Inflammatory bowel disease and cancer: the role of inflammation, immunosuppression, and cancer treatment","volume":"22","author":"Axelrad","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0580","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/DCR.0000000000001188","article-title":"A changing Spectrum of colorectal Cancer biology with age: implications for the young patient","volume":"62","author":"Chouhan","year":"2019","journal-title":"Dis. Colon Rectum."},{"issue":"9","key":"10.1016\/j.semcancer.2019.05.001_bib0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2012.06.016","article-title":"Effects of cancer treatment on inflammatory bowel disease remission and reactivation","volume":"10","author":"Axelrad","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.semcancer.2019.05.001_bib0590","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","article-title":"Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment","volume":"13","author":"Morgan","year":"2012","journal-title":"Genome Biol."},{"issue":"9","key":"10.1016\/j.semcancer.2019.05.001_bib0595","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.clon.2018.06.007","article-title":"Short-term toxicity of high dose rate brachytherapy in prostate Cancer patients with inflammatory bowel disease","volume":"30","author":"Mohammed","year":"2018","journal-title":"Clin. Oncol. R. Coll. Radiol."},{"issue":"8","key":"10.1016\/j.semcancer.2019.05.001_bib0600","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/MEG.0000000000000891","article-title":"Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland","volume":"29","author":"Bahler","year":"2017","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.semcancer.2019.05.001_bib0605","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/apt.12651","article-title":"Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis","volume":"39","author":"Castano-Milla","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.semcancer.2019.05.001_bib0610","first-page":"357","article-title":"Advances in the diagnosis and management of colonic dysplasia in patients with inflammatory bowel disease","volume":"13","author":"Cohen-Mekelburg","year":"2017","journal-title":"Gastroenterol. Hepatol. (N Y)"},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0615","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12916-017-0944-z","article-title":"Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance","volume":"15","author":"Westwood","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0620","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.critrevonc.2015.08.005","article-title":"Gastrointestinal cancers in inflammatory bowel disease: an update with emphasis on imaging findings","volume":"97","author":"Barral","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0625","first-page":"53","article-title":"Current management of inflammatory bowel disease and colorectal cancer","volume":"4","author":"Mattar","year":"2011","journal-title":"Gastrointest. Cancer Res."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0630","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3748\/wjg.15.61","article-title":"Colorectal cancer surveillance in inflammatory bowel disease: the search continues","volume":"15","author":"Ahmadi","year":"2009","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.semcancer.2019.05.001_bib0635","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/apt.12682","article-title":"Systematic review with meta-analysis: the incidence of advanced neoplasia after polypectomy in patients with and without low-risk adenomas","volume":"39","author":"Hassan","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.semcancer.2019.05.001_bib0640","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00384-017-2754-3","article-title":"A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer","volume":"32","author":"Reynolds","year":"2017","journal-title":"Int. J. Colorectal Dis."},{"issue":"5","key":"10.1016\/j.semcancer.2019.05.001_bib0645","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1158\/0008-5472.CAN-10-1966","article-title":"Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation","volume":"71","author":"Risques","year":"2011","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0650","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ilar\/ilv030","article-title":"The intestinal microbiota in inflammatory bowel disease","volume":"56","author":"Becker","year":"2015","journal-title":"ILAR J."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0655","first-page":"9","article-title":"The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease","author":"Zuo","year":"2018","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.semcancer.2019.05.001_bib0660","doi-asserted-by":"crossref","first-page":"S-863","DOI":"10.1016\/S0016-5085(18)32919-6","article-title":"Mo1955-an altered composition of the microbiome in microscopic colitis is driven towards the composition in healthy controls by treatment with budesonide","volume":"154","author":"Krogsgaard","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0665","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s10620-018-5313-z","article-title":"Proinflammatory sulfur-reducing bacteria are more abundant in colonic biopsies of patients with microscopic colitis compared to healthy controls","volume":"64","author":"Millien","year":"2019","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0670","article-title":"The gut microbiota heterogeneity and assembly changes associated with the IBD","volume":"9","author":"Sun","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0675","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3748\/wjg.v25.i2.151","article-title":"Role of diet and gut microbiota on colorectal cancer immunomodulation","volume":"25","author":"De Almeida","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0680","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3389\/fmicb.2019.00826","article-title":"Identifying gut microbiota associated with colorectal Cancer Using a zero-inflated lognormal model","volume":"10","author":"Ai","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0685","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev-cancerbio-030617-050240","article-title":"The impact of the gut microbiome on colorectal cancer","volume":"2","author":"Maisonneuve","year":"2018","journal-title":"Annu. Rev. Cancer Biol."},{"issue":"7","key":"10.1016\/j.semcancer.2019.05.001_bib0690","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00384-018-3069-8","article-title":"Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases","volume":"33","author":"Nikolaus","year":"2018","journal-title":"Int. J. Colorectal Dis."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0695","first-page":"1","article-title":"IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting","volume":"26","author":"Moschen","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0700","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/j.gastro.2018.05.022","article-title":"Variation in interleukin 6 receptor gene associates with risk of Crohn\u2019s disease and ulcerative colitis","volume":"155","author":"Parisinos","year":"2018","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0705","doi-asserted-by":"crossref","first-page":"401","DOI":"10.21037\/tcr.2018.03.37","article-title":"The association of interleukin-6 gene polymorphism and risk of colorectal cancer in Chinese patients","volume":"7","author":"Wang","year":"2018","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0710","first-page":"2","article-title":"GNAI1 and GNAI3 reduce colitis-associated tumorigenesis in mice by blocking IL6 signaling and downregulating expression of GNAI2","author":"Li","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.semcancer.2019.05.001_bib0715","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.gastro.2018.09.059","article-title":"Interleukin-6 receptor and inflammatory bowel disease: a Mendelian randomization study","volume":"156","author":"Liu","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0720","first-page":"1914","article-title":"High\u2011fat diets promote colon orthotopic transplantation tumor metastasis in BALB\/c mice","volume":"17","author":"Xiu","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0725","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)32592-3","article-title":"Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study","author":"Hyams","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2019.05.001_bib0730","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijsu.2019.03.016","article-title":"Preoperative exposure to anti-tumor Necrosis factor therapy in ulcerative colitis patients undergoing Ileal POUCH-ANAL anastomosis (IPAA) is not associated with histological fibrosis: A Case control study","volume":"65","author":"Zittan","year":"2019","journal-title":"Int. J. Surg."},{"issue":"8","key":"10.1016\/j.semcancer.2019.05.001_bib0735","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3390\/ijms20081887","article-title":"Tumour necrosis factor alpha in intestinal homeostasis and gut related diseases","volume":"20","author":"Ruder","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0740","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181750","article-title":"Associations of tumor necrosis factor-\u03b1 polymorphisms with the risk of colorectal cancer: a meta-analysis","volume":"39","author":"Huang","year":"2019","journal-title":"Biosci. Rep."},{"issue":"8","key":"10.1016\/j.semcancer.2019.05.001_bib0745","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3389\/fimmu.2017.00942","article-title":"Interactions between intestinal microbiota and host immune response in inflammatory bowel disease","volume":"14","author":"Zhang","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0750","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3389\/fimmu.2018.01212","article-title":"Effector T helper cell subsets in inflammatory bowel diseases","volume":"9","author":"Imam","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0755","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/cells8010007","article-title":"Impact of autophagy of innate immune cells on inflammatory bowel disease","volume":"8","author":"Iida","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.semcancer.2019.05.001_bib0760","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short Chain Fatty Acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases","volume":"10","author":"Venegas","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0765","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1053\/gast.2001.23231","article-title":"Smoking cessation and the course of Crohn\u2019s disease: an intervention study","volume":"120","author":"Cosnes","year":"2001","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.semcancer.2019.05.001_bib0770","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1542-3565(03)70037-8","article-title":"Cigarette smoking and colorectal cancer: long-term, subsite-specific risks in a cohort study of postmenopausal women","volume":"1","author":"Limburg","year":"2003","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0775","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.4065\/81.11.1462","article-title":"Smoking and inflammatory bowel disease: a meta-analysis","volume":"81","author":"Mahid","year":"2006","journal-title":"Mayo Clin. Proc."},{"issue":"25","key":"10.1016\/j.semcancer.2019.05.001_bib0780","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.3748\/wjg.14.3937","article-title":"Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies","volume":"14","author":"Lakatos","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.semcancer.2019.05.001_bib0785","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1158\/1055-9965.EPI-09-0661","article-title":"The association between cigarette smoking and risk of colorectal cancer in a large prospective cohort from the United States","volume":"18","author":"Hannan","year":"2009","journal-title":"Cancer Epidemiol. Prevent. Biomark."},{"issue":"7","key":"10.1016\/j.semcancer.2019.05.001_bib0790","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.crohns.2011.12.010","article-title":"Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis","volume":"6","author":"Calabrese","year":"2018","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.semcancer.2019.05.001_bib0795","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.crohns.2014.02.002","article-title":"Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect","volume":"8","author":"Parkes","year":"2014","journal-title":"J. Crohns Colitis"},{"issue":"6","key":"10.1016\/j.semcancer.2019.05.001_bib0800","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1053\/gast.2001.24052","article-title":"Family history as a risk factor for colorectal cancer in inflammatory bowel disease","volume":"120","author":"Askling","year":"2001","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.semcancer.2019.05.001_bib0805","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.crohns.2014.05.008","article-title":"Family history of inflammatory bowel disease among patients with ulcerative colitis: a systematic review and meta-analysis","volume":"8","author":"Childers","year":"2014","journal-title":"J. Crohns Colitis"},{"issue":"4","key":"10.1016\/j.semcancer.2019.05.001_bib0810","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.crohns.2013.09.001","article-title":"National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States","volume":"8","author":"Nguyen","year":"2014","journal-title":"J. Crohns Colitis"},{"issue":"3","key":"10.1016\/j.semcancer.2019.05.001_bib0815","article-title":"Genomic architecture of inflammatory bowel disease in five families with multiple affected individuals","volume":"7","author":"Stittrich","year":"2016","journal-title":"Hum. Genome Var."},{"issue":"8","key":"10.1016\/j.semcancer.2019.05.001_bib0820","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1097\/MIB.0000000000000835","article-title":"Racial and ethnic minorities with inflammatory bowel disease in the United States: a systematic review of disease characteristics and differences","volume":"22","author":"Afzali","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"10.1016\/j.semcancer.2019.05.001_bib0825","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/ecco-jcc\/jjx154","article-title":"Differences in clinical course, genetics, and the microbiome between familial and sporadic inflammatory bowel diseases","volume":"12","author":"Borren","year":"2017","journal-title":"J. Crohns Colitis"},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0830","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41435-018-0015-2","article-title":"Genetic variants and pathways implicated in a pediatric inflammatory bowel disease cohort","volume":"20","author":"Shaw","year":"2019","journal-title":"Genes Immun."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0835","first-page":"14","article-title":"Familial and ethnic risk in inflammatory bowel disease","volume":"31","author":"Santos","year":"2018","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0840","doi-asserted-by":"crossref","first-page":"l803","DOI":"10.1136\/bmj.l803","article-title":"Familial colorectal cancer risk in half siblings and siblings: nationwide cohort study","volume":"364","author":"Tian","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.semcancer.2019.05.001_bib0845","doi-asserted-by":"crossref","first-page":"j3951","DOI":"10.1136\/bmj.j3951","article-title":"Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014","volume":"358","author":"Ol\u00e9n","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.semcancer.2019.05.001_bib0850","first-page":"15","article-title":"Peer reviewed: age-specific risk factors for advanced stage colorectal Cancer, 1981\u20132013","author":"Moore","year":"2018","journal-title":"Prev. Chronic Dis."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0855","first-page":"4","article-title":"Inflammatory bowel disease and the risk of prostate cancer","author":"Burns","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0860","first-page":"1","article-title":"Diabetes mellitus and age are risk factors of interval Colon Cancer: a case-control study","volume":"7","author":"Laish","year":"2019","journal-title":"Dig. Dis."},{"issue":"5","key":"10.1016\/j.semcancer.2019.05.001_bib0865","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/ajcn\/85.5.1353","article-title":"Dietary fiber and whole-grain consumption in relation to colorectal cancer in the NIH-AARP Diet and Health Study","volume":"85","author":"Schatzkin","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.semcancer.2019.05.001_bib0870","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.dld.2011.10.001","article-title":"Diet and risk of inflammatory bowel disease","volume":"44","author":"Andersen","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0875","article-title":"Dietary interventions for induction and maintenance of remission in inflammatory bowel disease","volume":"2","author":"Limketkai","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0880","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000494022","article-title":"Patient\u2019s dietary beliefs and behaviours in inflammatory bowel disease","volume":"37","author":"deVries","year":"2019","journal-title":"Dig. Dis."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0885","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7812\/TPP\/18-107","article-title":"Westernized diet is the most ubiquitous environmental factor in inflammatory bowel disease","volume":"23","author":"Chiba","year":"2019","journal-title":"Perm J."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0890","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/nu11010164","article-title":"Colorectal cancer and nutrition","volume":"11","author":"Thanikachalam","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.semcancer.2019.05.001_bib0895","first-page":"17","article-title":"Diet and colorectal cancer in UK Biobank: a prospective study","author":"Bradbury","year":"2019","journal-title":"Int. J. Epidemiol."},{"issue":"12","key":"10.1016\/j.semcancer.2019.05.001_bib0900","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1158\/1055-9965.EPI-07-0708","article-title":"Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events","volume":"16","author":"Moghaddam","year":"2017","journal-title":"Cancer Epidemiol. Prevent. Biomark."},{"issue":"7","key":"10.1016\/j.semcancer.2019.05.001_bib0905","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/j.crohns.2012.09.009","article-title":"High prevalence of overweight and obesity in adults with Crohn\u2019s disease: associations with disease and lifestyle factors","volume":"7","author":"NicSuibhne","year":"2013","journal-title":"J. Crohns Colitis"},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0910","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/MIB.0000000000000283","article-title":"Measures of obesity and risk of Crohn\u2019s disease and ulcerative colitis","volume":"21","author":"Khalili","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0915","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbadis.2018.10.020","article-title":"The role of obesity in inflammatory bowel disease","volume":"1865","author":"Kreuter","year":"2018","journal-title":"Biochim Biophys Acta (BBA)-Mol Basis Dis"},{"key":"10.1016\/j.semcancer.2019.05.001_bib0920","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7406078","article-title":"Epigenetic influences in the obesity\/colorectal cancer axis: a novel theragnostic avenue","author":"Ayers","year":"2019","journal-title":"J. Oncol."},{"issue":"3","key":"10.1016\/j.semcancer.2019.05.001_bib0925","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/S2468-2667(19)30017-9","article-title":"Rising cancer incidence in younger adults: is obesity to blame?","volume":"4","author":"Marinac","year":"2019","journal-title":"Lancet Public Health"},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0930","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jamaoncol.2018.4280","article-title":"Association of obesity with risk of early-onset colorectal cancer among women","volume":"5","author":"Liu","year":"2019","journal-title":"JAMA Oncol."},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0935","first-page":"214","article-title":"Metabolic syndrome components including high abdominal obesity and sarcopenia in patients with inflammatory bowel disease","volume":"32","author":"Kountouras","year":"2019","journal-title":"Ann. Gastroenterol."},{"issue":"10","key":"10.1016\/j.semcancer.2019.05.001_bib0940","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/ibd.22906","article-title":"Micronutrient deficiencies in inflammatory bowel disease: from A to zinc","volume":"18","author":"Hwang","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib0945","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jnci\/djy087","article-title":"Circulating vitamin D and colorectal cancer risk: an international pooling project of 17 cohorts","volume":"111","author":"McCullough","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.semcancer.2019.05.001_bib0950","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.gtc.2017.08.011","article-title":"Vitamins and minerals in inflammatory bowel disease","volume":"46","author":"Ghishan","year":"2017","journal-title":"Gastroenterol. Clin. North Am."},{"issue":"4","key":"10.1016\/j.semcancer.2019.05.001_bib0955","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000489010","article-title":"High prevalence of vitamin D deficiency among patients with inflammatory bowel disease","volume":"2","author":"Caviezel","year":"2017","journal-title":"Inflamm. Intest. Dis."},{"key":"10.1016\/j.semcancer.2019.05.001_bib0960","first-page":"1","article-title":"Managing vitamin D deficiency in inflammatory bowel disease","volume":"0","author":"Nielsen","year":"2019","journal-title":"Frontline Gastroenterol."},{"issue":"Suppl. 1","key":"10.1016\/j.semcancer.2019.05.001_bib0965","article-title":"Calcium and\/or vitamin D supplementation: could they affect your risks of colorectal cancer development or progression?","volume":"6","author":"Ferguson","year":"2018","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib0970","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13148-018-0578-9","article-title":"Comprehensive methylation analysis of imprinting-associated differentially methylated regions in colorectal cancer","volume":"10","author":"Hidaka","year":"2018","journal-title":"Clin. Epigenet."},{"issue":"7702","key":"10.1016\/j.semcancer.2019.05.001_bib0975","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-018-0024-3","article-title":"Intra-tumour diversification in colorectal cancer at the single-cell level","volume":"556","author":"Roerink","year":"2018","journal-title":"Nature"},{"issue":"35","key":"10.1016\/j.semcancer.2019.05.001_bib0980","doi-asserted-by":"crossref","first-page":"59592","DOI":"10.18632\/oncotarget.19233","article-title":"Meta-analysis of the association between the inflammatory potential of diet and colorectal cancer risk","volume":"8","author":"Fan","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.semcancer.2019.05.001_bib0985","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S1542-3565(04)00543-9","article-title":"Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County","volume":"2","author":"Winther","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.semcancer.2019.05.001_bib0990","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/ecco-jcc\/jjx040","article-title":"Cancer risk in the early stages of inflammatory bowel disease in korean patients: a nationwide population-based study","volume":"11","author":"Jung","year":"2017","journal-title":"J. Crohns Colitis"},{"issue":"10","key":"10.1016\/j.semcancer.2019.05.001_bib0995","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1002\/ijc.30284","article-title":"Family history and the risk of colorectal cancer: the importance of patients\u2019 history of colonoscopy","volume":"139","author":"Weigl","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib1000","doi-asserted-by":"crossref","first-page":"G7","DOI":"10.1152\/ajpgi.00079.2004","article-title":"Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation","volume":"287","author":"Itzkowitz","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.semcancer.2019.05.001_bib1005","article-title":"Close interplay of nitro-oxidative stress, advanced glycation end products and inflammation in inflammatory bowel diseases","author":"Moura","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.semcancer.2019.05.001_bib1010","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5126048","article-title":"The role of proinflammatory pathways in the pathogenesis of colitis-associated colorectal Cancer","volume":"2017","author":"Luo","year":"2017","journal-title":"Mediators Inflamm."},{"issue":"7","key":"10.1016\/j.semcancer.2019.05.001_bib1015","first-page":"2727","article-title":"Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies","volume":"29","author":"Triantafillidis","year":"2009","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib1020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/apt.15076","article-title":"Comorbid immune-mediated diseases in inflammatory bowel disease: a nation-wide population-based study","volume":"49","author":"Park","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.semcancer.2019.05.001_bib1025","article-title":"Loss of RNF40 decreases NF-kappaB activity in colorectal cancer cells and reduces colitis burden in mice","author":"Kosinsky","year":"2018","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.semcancer.2019.05.001_bib1030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.12659\/MSMBR.903910","article-title":"TNF-alpha promotes invasion and metastasis via NF-Kappa B pathway in oral squamous cell carcinoma","volume":"23","author":"Tang","year":"2017","journal-title":"Med. Sci. Monit. Basic Res."},{"key":"10.1016\/j.semcancer.2019.05.001_bib1035","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.22416","article-title":"YOD1\/TRAF6 association balances p62-dependent IL-1 signaling to NF-kappaB","volume":"6","author":"Schimmack","year":"2017","journal-title":"eLife"},{"issue":"22","key":"10.1016\/j.semcancer.2019.05.001_bib1040","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.1158\/0008-5472.CAN-18-2063","article-title":"An ATM\/TRIM37\/NEMO axis counteracts genotoxicity by activating nuclear-to-cytoplasmic NF-kappaB signaling","volume":"78","author":"Wu","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2019.05.001_bib1045","article-title":"Abrogation of cathepsin C by Helicobacter pylori impairs neutrophil activation to promote gastric infection","author":"Liu","year":"2018","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.semcancer.2019.05.001_bib1050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006561","article-title":"A parapoxviral virion protein inhibits NF-kappaB signaling early in infection","volume":"13","author":"Khatiwada","year":"2017","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.semcancer.2019.05.001_bib1055","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1159\/000485452","article-title":"Molecular mechanism of MiR-136-5p targeting NF-kappaB\/A20 in the IL-17-Mediated inflammatory response after spinal cord injury","volume":"44","author":"He","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.semcancer.2019.05.001_bib1060","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01776","article-title":"p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-kappaB complexes","volume":"3","author":"Krawczyk","year":"2014","journal-title":"eLife"},{"issue":"7","key":"10.1016\/j.semcancer.2019.05.001_bib1065","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1096\/fj.201700941RR","article-title":"CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78)","volume":"32","author":"Aran","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.semcancer.2019.05.001_bib1070","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.biopha.2015.07.024","article-title":"BDMC-A, an analog of curcumin, inhibits markers of invasion, angiogenesis, and metastasis in breast cancer cells via NF-kappaB pathway\u2014a comparative study with curcumin","volume":"74","author":"Mohankumar","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.semcancer.2019.05.001_bib1075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.plefa.2016.01.005","article-title":"Prostaglandin E(2) possesses different potencies in inducing Vascular Endothelial Growth Factor and Interleukin-8 production in COPD human lung fibroblasts","volume":"106","author":"Bonanno","year":"2016","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"8","key":"10.1016\/j.semcancer.2019.05.001_bib1080","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/ibd.21217","article-title":"Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease","volume":"16","author":"O\u2019Connor","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.semcancer.2019.05.001_bib1085","article-title":"Antineoplastic influence of nimesulide in chemically induced hepatocellular carcinoma by inhibition of DNA synthesis","author":"Afzal","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.semcancer.2019.05.001_bib1090","article-title":"Effect of anticoagulants and NSAIDs on accuracy of faecal immunochemical tests (FITs) in colorectal cancer screening: a systematic review and meta-analysis","author":"Nieuwenburg","year":"2018","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.semcancer.2019.05.001_bib1095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082332","article-title":"Clinically relevant anti-inflammatory agents for chemoprevention of colorectal Cancer: new perspectives","volume":"19","author":"Mohammed","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.semcancer.2019.05.001_bib1100","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2174\/0929866523666161007151812","article-title":"Dynamics of radical intermediates in prostaglandin H Synthase-1 cyclooxygenase reactions is modulated by multiple factors","volume":"23","author":"Wu","year":"2016","journal-title":"Protein Pept. Lett."},{"issue":"1","key":"10.1016\/j.semcancer.2019.05.001_bib1105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.bjp.0704028","article-title":"Regulation of prostacyclin and prostaglandin E(2) receptor mediated responses in adult rat dorsal root ganglion cells, in vitro","volume":"133","author":"Rowlands","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.semcancer.2019.05.001_bib1110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/cei.12931","article-title":"Constitutive expression of the anti-apoptotic Bcl-2 family member A1 in murine endothelial cells leads to transplant tolerance","volume":"188","author":"Smyth","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.semcancer.2019.05.001_bib1115","first-page":"1","author":"Tafakh","year":"2018","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.semcancer.2019.05.001_bib1120","first-page":"1","article-title":"Total glycosides of peony protects against inflammatory bowel disease by regulating IL-23\/IL-17 Axis and Th17\/Treg balance","author":"Li","year":"2019","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.semcancer.2019.05.001_bib1125","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.3389\/fimmu.2018.02347","article-title":"IL-17RA-Signaling modulates CD8+ t cell survival and exhaustion during trypanosoma cruzi infection","volume":"9","author":"Tosello Boari","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.semcancer.2019.05.001_bib1130","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1053\/j.gastro.2007.03.104","article-title":"Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice","volume":"132","author":"Elson","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2019.05.001_bib1135","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/297645","article-title":"Interleukin-23 and Th17 cells in the control of gut inflammation","volume":"2009","author":"Monteleone","year":"2009","journal-title":"Mediators Inflamm."},{"issue":"10","key":"10.1016\/j.semcancer.2019.05.001_bib1140","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1136\/gut.2006.115402","article-title":"The IL23 axis plays a key role in the pathogenesis of IBD","volume":"56","author":"McGovern","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.semcancer.2019.05.001_bib1145","article-title":"Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map","author":"Huynh","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2019.05.001_bib1150","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1562010","article-title":"Chemopreventive effects of Silibinin on colitis-associated tumorigenesis by inhibiting IL-6\/STAT3 signaling pathway","volume":"2018","author":"Zheng","year":"2018","journal-title":"Mediators Inflamm."},{"issue":"3","key":"10.1016\/j.semcancer.2019.05.001_bib1155","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/cei.13151","article-title":"BCL-2 levels do not predict azathioprine treatment response in inflammatory bowel disease, but inhibition induces lymphocyte apoptosis and ameliorates colitis in mice","volume":"193","author":"Weder","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.semcancer.2019.05.001_bib1160","article-title":"Upregulation of mtSSB by interleukin-6 promotes cell growth through mitochondrial biogenesis-mediated telomerase activation in colorectal cancer","author":"Wang","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2019.05.001_bib1165","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.12659\/MSM.907439","article-title":"Targeting Interleukin-6 (IL-6) sensitizes Anti-PD-L1 treatment in a colorectal Cancer Preclinical model","volume":"24","author":"Li","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.semcancer.2019.05.001_bib1170","doi-asserted-by":"crossref","DOI":"10.1080\/15384101.2018.1556064","article-title":"TGF-beta secreted by tumor-associated macrophages promotes proliferation and invasion of colorectal cancer via miR-34a-VEGF axis","author":"Zhang","year":"2018","journal-title":"Cell Cycle"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X19300161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X19300161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:41:42Z","timestamp":1760917302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X19300161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":234,"alternative-id":["S1044579X19300161"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2019.05.001","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of colorectal cancer in inflammatory bowel diseases","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2019.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}